# Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer

> **NCT05010759** · NA · TERMINATED · sponsor: **MagForce USA** · enrollment: 3 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** NanoTherm Ablation

## Key facts

- **NCT ID:** NCT05010759
- **Lead sponsor:** MagForce USA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-11-30
- **Primary completion:** 2023-07-28
- **Final completion:** 2023-07-28
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Inadequate enrollment and company changing direction
- **Last updated:** 2023-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05010759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05010759, "Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05010759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*